对帕金森病的多巴胺能神经元进行重编程的表观遗传动力学
Byounggook Cho1, Junyeop Kim1, Sumin Kim1
1Laboratory of Stem Cells & Cell Reprogramming, Department of Chemistry and Biomedical Engineering, Dongguk University, Seoul, 04620, Republic of Korea.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|September 16, 2024
概括
研究人员确定了一个关键调节器,Arid4b,对于直接血统重编程到多巴胺基 (DA) 神经元至关重要. 增强Arid4b可以提高DA神经元的产量,并逆转帕金森症.
科学领域:
- 神经科学是一个神经科学.
- 干细胞生物学 干细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 直接血统重编程旨在产生特定的细胞类型,如多巴胺基 (DA) 神经元,用于治疗应用,特别是帕金森病 (PD).
- 目前的重编程方法面临着不清楚路径的挑战,导致不成熟或不可活的DA神经元的低效生成.
研究的目的:
- 为了阐明细胞轨迹,并确定参与直接血统重编程到功能多巴胺基神经元的关键调节者.
- 为了提高诱导的DA神经元 (iDA神经元) 的效率和成熟度,用于潜在的PD疗法.
主要方法:
- 使用单细胞RNA测序来分析多个时间点的重编程轨迹.
- 对细胞群体进行了纵向剖析,以确定不同的重编程途径.
- 通过在PD小鼠模型中进行过度表达研究,对已识别的调节剂进行了功能验证.
主要成果:
- 确定了一条连续的重编程途径,突出显示了早期中介细胞群的关键作用.
- 发现了两个不同的轨迹:一个成功的,一个导致死胡同的状态.
- 鉴定出Arid4b是一种基因素修饰剂,它是分支点的关键调节器,对于成功的重编程和成熟的DA神经元认同至关重要.
- 在小鼠模型中,Arid4b的过度表达显著增加了iDA神经元产量,并改善了PD相关的表型.
结论:
- 了解直接血统重编程的细胞轨迹对于优化DA神经元生成至关重要.
- Arid4b是重编程成功和DA神经元成熟的关键决定因素,为帕金森病提供了潜在的治疗点.
- 这项研究为开发针对神经退行性疾病的更有效的再生医学策略提供了基础.
更多相关视频
12:13Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
Published on: July 11, 2019
7.2K
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.5K
相关概念视频
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:24Parkinson's Disease: Treatment
237
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
237
01:32Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
01:15Parkinson's Disease: Overview
498
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
498
01:37Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K